FETAL HEAD GROWTH RETARDATION ASSOCIATED WITH MATERNAL ANTIEPILEPTIC DRUGS
- 1 July 1981
- journal article
- research article
- Published by Elsevier in The Lancet
- Vol. 318 (8239), 165-167
- https://doi.org/10.1016/s0140-6736(81)90354-8
Abstract
No abstract availableThis publication has 7 references indexed in Scilit:
- CONVERSION SCALES FOR COMMONLY REQUESTED SERUM CONCENTRATIONS OF DRUGS AND OTHER SUBSTANCES OF THERAPEUTIC AND TOXICOLOGICAL IMPORTANCE, AND OF HORMONESThe Lancet, 1980
- Assessing birth weight-for-dates on a continuous scaleAnnals of Human Biology, 1980
- Neuronal deficits in mice following prenatal exposure to phenobarbitalExperimental Neurology, 1979
- Committee on Drugs Anticonvulsants and PregnancyPediatrics, 1979
- Comparative study of the teratogenicity of phenobarbitone, diphenlhydatoin and carbamazepine in miceToxicology, 1976
- Risks to the offspring of women treated with hydantoin anticonvulsants, with emphasis on the fetal hydantoin syndromeThe Journal of Pediatrics, 1976
- Neonatometer: A New Infant Length MeasurerArchives of Disease in Childhood, 1972